Multiple Independent Molecular Signals Converge to Validate GRI-0621 as a Potential Disease-Modifying Therapy LA JOLLA, CA, Jan. 28, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or ...
NASA's plans for Mars sample return are effectively cancelled as part of a bill approved by the U.S. Congress, ending efforts to collect Perseverance rover samples that could contain evidence of alien ...
"There are incredibly tantalizing samples in the Perseverance rover's cache that could revolutionize our understanding of life in the solar system." When you purchase through links on our site, we may ...
Aimee Picchi is the associate managing editor for CBS MoneyWatch, where she covers business and personal finance. She previously worked at Bloomberg News and has written for national news outlets ...
Also Read: ImmunityBio Slapped With FDA Refusal To File Letter For Expanded Use Of Its Bladder Cancer Drug Specific key efficacy findings from cohort B (N=80) of the Phase 2/3 open-label, single-arm ...
A newly enacted New York law requires retailers to say whether your data influences the price of basic goods like a dozen eggs or toilet paper, but not how. If you’re near Rochester, New York, the ...
Copyright: © 2025 The Author(s). Published by Elsevier Ltd. Individual prediction uncertainty is a key aspect of clinical prediction model performance; however ...
IRVINE, Calif., Nov. 20, 2025 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotechnology company developing novel therapies for relapsed and refractory (r/r) B-cell malignancies, announced ...
On Election Day, Peter Hubbard was one of two Democratic candidates who took a decisive—and surprising—victory in Georgia. Hubbard was elected to the Georgia Public Service Commission, the body that ...
Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...
Adocia SA is looking to further apply its Biochaperone formulation technology to metabolic disorders, Olivier Soula, Adocia co-founder and CEO told BioWorld, the firm having recently gained positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results